Predictive Factors for Response to Rituximab in Waldenström's Macroglobulinemia

Meletios A Dimopoulos; Athanasios K. Anagnostopoulos; Constantinos Zervas; Marie Christine Kyrtsonis; Athanasios Zomas; Constantinos L. Bourantas; Nicolaos Anagnostopoulos; Gerassimos A. Pangalis

doi:10.3816/clm.2005.n.014

Related publications

Article2005

Predictive Factors for Response and Progression after Treatment with Rituximab in Previously Untreated Patients with Waldenstrom’s Macroglobulinemia (WM).

Athanasios K. Anagnostopoulos, Steven P. Treon, Konstantinos Zervas, Andrew R. Branagan, Dimitra Gika, Athanasios Zomas, Marie Christine Kyrtsonis, Amalia Vassou, Nikolaos Anagnostopoulos, Gerasimos Pangalis, Meletios A Dimopoulos

Article2004

Treatment of Waldenstrom's Macroglobulinemia with Rituximab: Prognostic Factors for Response and Progression

Meletios A Dimopoulos, Raymond Alexanian, Dimitra Gika, Athanasios K. Anagnostopoulos, Constantinos Zervas, Athanassios Zomas, Marie Christine Kyrtsonis, Nicolaos Anagnostopoulos, Gerassimos A. Pangalis, Donna M. Weber

Article2009

Rituximab-Based Treatments in Waldenström's Macroglobulinemia

Meletios A Dimopoulos, Efstathios Kastritis, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Magdalini Migkou, Maria Gavriatopoulou, Anna Tassidou, Evangelos Terpos

Article2002

Treatment of Waldenström’s Macroglobulinemia With Rituximab

Meletios A Dimopoulos, Constantinos Zervas, Athanassios Zomas, Christos Kiamouris, Nora Viniou, Vassiliki Grigoraki, Christos Karkantaris, Chrisanthi Mitsouli, Dimitra Gika, John Christakis, Nikolaos Anagnostopoulos

Article2002

Extended Rituximab Therapy for Previously Untreated Patients with Waldenström's Macroglobulinemia

Meletios A Dimopoulos, Constantinos Zervas, Athanasios Zomas, George Hamilos, Dimitra Gika, Eleni Efstathiou, Panayiotis Panayiotidis, Elina Vervessou, Nikolaos Anagnostopoulos, John Christakis